The Drug aimed at helping women who have lost their sex drive has taken a huge step in the positive direction and has been backed by an FDA panel. The FDA advisory committee voted 18-6 to persuade that the FDA approve the drug flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women. More details after the jump.